These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 15006365)
1. Terephthalamide derivatives as mimetics of the helical region of Bak peptide target Bcl-xL protein. Yin H; Hamilton AD Bioorg Med Chem Lett; 2004 Mar; 14(6):1375-9. PubMed ID: 15006365 [TBL] [Abstract][Full Text] [Related]
2. Terephthalamide derivatives as mimetics of helical peptides: disruption of the Bcl-x(L)/Bak interaction. Yin H; Lee GI; Sedey KA; Rodriguez JM; Wang HG; Sebti SM; Hamilton AD J Am Chem Soc; 2005 Apr; 127(15):5463-8. PubMed ID: 15826183 [TBL] [Abstract][Full Text] [Related]
3. Terphenyl-Based Bak BH3 alpha-helical proteomimetics as low-molecular-weight antagonists of Bcl-xL. Yin H; Lee GI; Sedey KA; Kutzki O; Park HS; Orner BP; Ernst JT; Wang HG; Sebti SM; Hamilton AD J Am Chem Soc; 2005 Jul; 127(29):10191-6. PubMed ID: 16028929 [TBL] [Abstract][Full Text] [Related]
4. Bcl-xl and Bak protein expression in human optic nerve axons in eyeballs post-trauma and in the eyes with absolute glaucoma. Reszeć J; Zalewska R; Mariak Z; Sulkowski S Rocz Akad Med Bialymst; 2004; 49 Suppl 1():19-21. PubMed ID: 15638362 [TBL] [Abstract][Full Text] [Related]
5. [The expression of Bcl-2, Bcl-xl, Bak and Bax proteins in axons of the optic nerve in closed-angle glaucoma]. Zalewska R; Reszeć J; Mariak Z; Sulkowski S Klin Oczna; 2004; 106(1-2 Suppl):155-7. PubMed ID: 15510481 [TBL] [Abstract][Full Text] [Related]
6. Development of a potent Bcl-x(L) antagonist based on alpha-helix mimicry. Kutzki O; Park HS; Ernst JT; Orner BP; Yin H; Hamilton AD J Am Chem Soc; 2002 Oct; 124(40):11838-9. PubMed ID: 12358513 [TBL] [Abstract][Full Text] [Related]
7. (alpha/beta+alpha)-peptide antagonists of BH3 domain/Bcl-x(L) recognition: toward general strategies for foldamer-based inhibition of protein-protein interactions. Sadowsky JD; Fairlie WD; Hadley EB; Lee HS; Umezawa N; Nikolovska-Coleska Z; Wang S; Huang DC; Tomita Y; Gellman SH J Am Chem Soc; 2007 Jan; 129(1):139-54. PubMed ID: 17199293 [TBL] [Abstract][Full Text] [Related]
8. Modulation of the membrane orientation and secondary structure of the C-terminal domains of Bak and Bcl-2 by lipids. Torrecillas A; Martínez-Senac MM; Goormaghtigh E; de Godos A; Corbalán-García S; Gómez-Fernández JC Biochemistry; 2005 Aug; 44(32):10796-809. PubMed ID: 16086582 [TBL] [Abstract][Full Text] [Related]
9. Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies. Petros AM; Nettesheim DG; Wang Y; Olejniczak ET; Meadows RP; Mack J; Swift K; Matayoshi ED; Zhang H; Thompson CB; Fesik SW Protein Sci; 2000 Dec; 9(12):2528-34. PubMed ID: 11206074 [TBL] [Abstract][Full Text] [Related]
10. Design and application of an alpha-helix-mimetic scaffold based on an oligoamide-foldamer strategy: antagonism of the Bak BH3/Bcl-xL complex. Ernst JT; Becerril J; Park HS; Yin H; Hamilton AD Angew Chem Int Ed Engl; 2003 Feb; 42(5):535-9. PubMed ID: 12569483 [No Abstract] [Full Text] [Related]
11. Structure and function of benzoylurea-derived alpha-helix mimetics targeting the Bcl-x(L)/Bak binding interface. Rodriguez JM; Ross NT; Katt WP; Dhar D; Lee GI; Hamilton AD ChemMedChem; 2009 Apr; 4(4):649-56. PubMed ID: 19330783 [TBL] [Abstract][Full Text] [Related]
12. A system based on specific protein-RNA interactions for analysis of target protein-protein interactions in vitro: successful selection of membrane-bound Bak-Bcl-xL proteins in vitro. Sawata SY; Suyama E; Taira K Protein Eng Des Sel; 2004 Jun; 17(6):501-8. PubMed ID: 15292519 [TBL] [Abstract][Full Text] [Related]
13. Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis. Sattler M; Liang H; Nettesheim D; Meadows RP; Harlan JE; Eberstadt M; Yoon HS; Shuker SB; Chang BS; Minn AJ; Thompson CB; Fesik SW Science; 1997 Feb; 275(5302):983-6. PubMed ID: 9020082 [TBL] [Abstract][Full Text] [Related]
14. Bak but not Bax is essential for Bcl-xS-induced apoptosis. Lindenboim L; Kringel S; Braun T; Borner C; Stein R Cell Death Differ; 2005 Jul; 12(7):713-23. PubMed ID: 15861188 [TBL] [Abstract][Full Text] [Related]
15. In vitro effects of inhibin on apoptosis and apoptosis related proteins in human ovarian granulosa cells. Denkova R; Bourneva V; Staneva-Dobrovski L; Zvetkova E; Baleva K; Yaneva E; Nikolov B; Ivanov I; Simeonov K; Timeva T; Yankov M Endocr Regul; 2004 Jun; 38(2):51-5. PubMed ID: 15497928 [TBL] [Abstract][Full Text] [Related]
16. Thiazolidenediones mediate apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 functions independently of PPARgamma. Shiau CW; Yang CC; Kulp SK; Chen KF; Chen CS; Huang JW; Chen CS Cancer Res; 2005 Feb; 65(4):1561-9. PubMed ID: 15735046 [TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships of Bak derived peptides: affinity and specificity modulations by amino acid replacement. Frey V; Viaud J; Subra G; Cauquil N; Guichou JF; Casara P; Grassy G; Chavanieu A Eur J Med Chem; 2008 May; 43(5):966-72. PubMed ID: 17692431 [TBL] [Abstract][Full Text] [Related]
18. Bcl-X(L) specifically activates Bak to induce swelling and restructuring of the endoplasmic reticulum. Klee M; Pimentel-Muiños FX J Cell Biol; 2005 Feb; 168(5):723-34. PubMed ID: 15728194 [TBL] [Abstract][Full Text] [Related]